CTRL + Rx Series

The CTRL + Rx Series dares pharma to imagine a world where the molecule bows to the algorithm, and trust is recoded in zeros and ones. These aren’t comfortable scenarios, they’re uncharted futures. From digital twins in clinical trials to AI becoming the drug rep, this series questions everything you thought you knew about care, consent and control.

In Pharma’s Digital Doppelgänger – When AI Becomes the Drug Rep, the MSL and the Patient (2026-2030) we forecast the day when the human in the loop may no longer be human. In Prescribed by Code. Approved by No One we explore how regulation, accountability and ethics might unravel under the weight of automation.

Across this provocative set you’ll also find explorations of sentient brands, invisible trials, and engagement models that never sleep. Other unsettling titles include: When the Algorithm Knows Your Doctor Better Than You Do and The Sentient Brand: When AI Builds its Own Reputation.

Each edition is published as premium dijee Intelligence Centre content, designed to unsettle assumptions, spark debate, and give pharma teams the foresight they need to face the edge of what’s next.

Not just insight – a wake-up call.